Sleep Number Corp (SNBR) CFO awarded 66,965 restricted stock units

Rhea-AI Filing Summary

O'Keefe Amy K reported acquisition or exercise transactions in this Form 4 filing.

Sleep Number Corp reported that EVP & Chief Financial Officer Amy K. O'Keefe received a grant of 66,965 shares of common stock as a stock award, with no cash paid per share. After this award, she holds 136,707 restricted stock units that will vest over time, increasing her equity-based compensation stake but not involving any open-market buying or selling.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider O'Keefe Amy K

Role EVP & Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	66,965	$0.00	--

Holdings After Transaction: Common Stock — 136,707 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Keefe Amy K

(Last) (First) (Middle)

1001 THIRD AVENUE SOUTH

(Street)

MINNEAPOLIS MN 55404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sleep Number Corp [ SNBR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		A		66,965	A	$0	136,707(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 136,707 Restricted Stock Units that will vest over time.

Remarks:

	/s/ Amy K. O'Keefe by Kelly Baker, attorney-in-fact	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Sleep Number (SNBR) disclose about CFO Amy O'Keefe's Form 4 transaction?

Sleep Number disclosed that EVP & CFO Amy K. O'Keefe received a stock award of 66,965 common shares. This grant is compensation-related and not an open-market trade, so it does not directly reflect a buy or sell decision in the market.

How many Sleep Number shares did the CFO receive in this Form 4 filing?

The CFO received 66,965 shares of Sleep Number common stock as a grant. The reported price per share was zero because this was an equity award rather than a purchase, reflecting compensation instead of an open-market investment transaction.

What is the CFO's Sleep Number equity position after this stock grant?

Following the grant, Amy K. O'Keefe is reported to hold 136,707 restricted stock units. According to the disclosure, these restricted units will vest over time, meaning ownership of the underlying shares becomes available gradually as vesting conditions are met.

Does the Sleep Number CFO Form 4 show any stock sales or purchases?

The Form 4 shows only an acquisition through a stock award, coded as a grant. There are no reported open-market purchases or sales, so the filing reflects compensation rather than trading activity that might signal a directional market view.

How will the Sleep Number CFO's restricted stock units vest over time?

The filing states that the 136,707 restricted stock units will vest over time. This means the CFO’s rights to the underlying shares increase gradually based on the company’s vesting schedule, aligning her compensation with longer-term company performance.